Skip to main content Skip to search Skip to main navigation

EC: Harmonised Standards for Medical Device Sterilisation

The European Commission adopted two implementing decisions on the sterilisation of medical devices. These decisions were made in accordance with the regulations governing medical devices and in vitro diagnostics (IVDs) in the EU.

Harmonised standards play a crucial role in ensuring compliance with regulatory requirements. To this end, the Commission collaborated with the European Committee for Standardization (CEN) and the European Committee for Electrotechnical Standardization (Cenelec) to revise existing standards and to develop new standards pertaining to the sterilization of various medical devices and diagnostics.

The Commission has incorporated the proposed standards into two implementing decisions. The first decision ((EU) 2024/817) adds three sterilization-related standards to an existing annex within the IVDs regulatory framework ((EU) 2021/1195). The second decision ((EU) 2024/815) extends this by incorporating sterilisation standards into an existing decision on medical devices ((EU) 2021/1182), together with additional guidance on, inter alia, medical gloves, packaging for terminally sterilised medical devices and health care products.


Sources:

Commission Implementing Decision (EU) 2024/817 of 6 March 2024

Commission Implementing Decision (EU) 2024/815 of 6 March 2024

Meet the GMP Compliance Adviser

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business. 

The demo access is non-binding and ends automatically.

Test it now for free

You may also be interested in the following articles:

EMA: Q&A Paper on Measures to Prevent Microbial Contamination of Non-Sterile Medicinal Products

EMA: Q&A Paper on Measures to Prevent Microbial Contamination of Non-Sterile Medicinal Products

The EMA has published a new Q&A paper on technical and organisational measures to prevent microbial contamination of non-sterile medicinal products.
Read more
When APS Fail and First Air is at Risk

When APS Fail and First Air is at Risk

At the PDA Good Aseptic Manufacturing Conference 2026, Alberto Gonzales (Takeda) discussed challenges and practical solutions related to aseptic process simulations (APS). Anna Campanella (Takeda) and Hussein Bachir (Franz Ziel) explored how first air protection in aseptic processing can be compromised by equipment design, glove interventions, and operator activities.
Read more
Why is import authorisation necessary for medicinal products entering the EU?

Why is import authorisation necessary for medicinal products entering the EU?

Read more
FDA: Updated Compliance Program for Preapproval Inspections

FDA: Updated Compliance Program for Preapproval Inspections

The FDA has revised its Compliance Program 7346.832, “Preapproval Inspections”. The updated program describes the planning, conduct and evaluation of preapproval inspections (PAIs) for New Drug Applications (NDAs) and Abbreviated New Drug Applications (ANDAs).
Read more
EMA: Revised Q&A MRA EU-USA

EMA: Revised Q&A MRA EU-USA

The EMA has updated its Questions and Answers on the EU-US Mutual Recognition Agreement (MRA). The update follows the completion of the FDA's assessment of all EU authorities responsible for GMP inspections of veterinary medicinal products on 29 May 2026.
Read more
WHO: Draft on Regulatory Ovesight of Disposal of Medical Products

WHO: Draft on Regulatory Ovesight of Disposal of Medical Products

WHO published a draft consultation document on regulatory oversight of disposal of medical products throughout the lifecycle.
Read more
Previous
Next